Cardiothoracic
Cosmetic and Plastic
Cryosurgery
Endoscopic
General
Head and Neck
Neurosurgery
Orthopedics
Cosmetic and Plastic
Cryosurgery
Endoscopic
General
Head and Neck
Neurosurgery
Orthopedics
Related Topics
Medical Specialties
Permanent Surgery Jobs
Easy Access to Large Metro * Upwards of $300K Starting Salary & Fast Partnership :: West Virginia :: The Curare Group, Inc.
JOB DETAILS $300,000 Annual Salary Production Incentive Excellent Long Term Earnings Signing Bonus Call, 1:4 Schedule Quick Partnership Track Currently Completing A Large Expansion Project
Great Outdoor Recreation Community ** $275K Salary + Production * Partnership! :: Maryland :: The Curare Group, Inc.
JOB DETAILS $275,000 Annual Salary Production Incentive Negotiable Sign On Bonus Call, 1:4 Schedule Single Specialty Practice Partnership Options Bread & Butter Surgeries With Some Advances
Crystal Coast Location Offers 1:3 Call Coverage & Exceptional Starting Salary :: North Dakota :: The Curare Group, Inc.
JOB DETAILS Competitive Salary Production Incentive Incentives Added To Salary Call, 1:3 Schedule Options Available For General Surgeon Hospital Employee Or Solo Excellent Referral Base Bread
MedPage Today Surgery
SABCS: No Cancer Benefit for Preop Bone Drug (CME/CE, with video)
Fri, 11 Dec 2009 14:36:56 -0400
SAN ANTONIO (MedPage Today) -- A preoperative dose of bone-building zoledronic acid (Zometa) won't kill breast cancer cells or halt their proliferation, researchers found.
FDA Heightens Warning about Negative Pressure Wound Therapy
Fri, 11 Dec 2009 12:48:47 -0400
WASHINGTON --The FDA has contacted healthcare professionals and patients to warn of a growing concern over rare but potentially fatal complications from negative pressure wound therapy.
SABCS: Novel Biologic Beats Zoledronic Acid for Bone Mets (CME/CE)
Fri, 11 Dec 2009 11:38:40 -0400
SAN ANTONIO (MedPage Today) -- The investigational monoclonal antibody denosumab relieves painful bone metastases and prevents their serious complications in breast cancer patients better than standard zoledronic acid (Zometa).
ASH: IV Iron Fails Test in Cancer-Related Anemia (CME/CE)
Thu, 10 Dec 2009 11:58:11 -0400
NEW ORLEANS (MedPage Today) -- Intravenous iron supplementation failed to boost the benefits of erythropoiesis-stimulating agents (ESAs) in cancer patients with chemotherapy-induced anemia, according to data from the largest study of its kind.
ASH: PTLD Responds to Immunosuppression Cutback (CME/CE)
Thu, 10 Dec 2009 09:02:43 -0400
NEW ORLEANS (MedPage Today) -- Reducing immunosuppression offers a safe and effective strategy to manage post-transplantation lymphoproliferative disorder (PTLD) after solid-organ or stem-cell transplant, according to a study reported here.
ASH: Lower Threshold for Post-op Transfusion Proves Safe (CME/CE)
Wed, 09 Dec 2009 15:00:38 -0400
NEW ORLEANS (MedPage Today) -- A restrictive transfusion policy reduced blood use by 50% and posed no increased hazards to older patients with cardiovascular disease who were undergoing surgery for hip fracture, data from an NIH-funded study showed.
Archives of Surgery current issue
About This Journal [About This Journal]
Is Use of Bone-Morphogenetic Proteins for Spine Fusion Surgery Cost-effective? [From JAMA]
Cardoso, M. J., Sciubba, D. M.
Managing Patients With Clinically Significant Cardiac and Carotid Artery Occlusive Disease [From the Archives]
Perler, B. A.
Websites
